Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

163
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
163
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

128
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

208
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
208

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same author

Revisiting Stereocontrol through Ligand-Directed Non-Covalent Interactions in the Asymmetric Synthesis of Tetrahydrofuran Cores via Tsuji-Trost Asymmetric Allylic Alkylation.

ACS omega·2026
Same author

CALPUCK: An Open Python Tool for Cremer-Pople Ring Puckering Analysis Including a New 2D Mapping of Seven-Membered Rings.

ChemPlusChem·2026
Same author

Pro-inflammatory intestinal Th17-cells are tissue-resident, accumulate in the epithelia in Crohn's disease, and predict unresponsiveness to vedolizumab.

Journal of Crohn's & colitis·2026
Same author

Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

Journal of medicinal chemistry·2026
Same author

Programmable Functionalizations of Tetramethylpiperidine N-Oxyl (TEMPO)-Acrolein Linchpins Derived from Alkoxyallenes.

Journal of the American Chemical Society·2026
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
Same journal

Recent Highlights in the Discovery and Design of Antibody-Drug Conjugates.

Journal of medicinal chemistry·2026
Same journal

One Face, Three Solutions: Structural Convergence in PD-L1 Inhibition across Antibodies, Macrocycles, and Small Molecules.

Journal of medicinal chemistry·2026
Same journal

A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic Activity.

Journal of medicinal chemistry·2026
Same journal

Structure-Based Discovery of (<i>E</i>)- and (<i>Z</i>)-4-Oxobut-2-enoate Derivatives as Novel Covalent Pin1 Inhibitors with Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

Hybrids of Benzenesulfonamide Oxadiazole Derivatives with Dual CA II and COX-2 Inhibitory Activity Demonstrating Antiglaucoma and Anti-inflammatory Action: Synthesis, In Silico Insights, and In Vitro and In Vivo Bioevaluation.

Journal of medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: May 24, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.5K

Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy.

Giulia Cazzaniga1,2, Matteo Mori1, Anna Griego1,3

  • 1Department of Pharmaceutical Sciences, University of Milan, Via L. Mangiagalli 25, 20133 Milano, Italy.

Journal of Medicinal Chemistry
|March 3, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed new compounds targeting a key enzyme in Mycobacterium tuberculosis (Mtb). These novel agents show promising antitubercular activity and were delivered using polymersomes, offering a new strategy for tuberculosis treatment.

More Related Videos

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.6K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Related Experiment Videos

Last Updated: May 24, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.5K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.6K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Tuberculosis Research

Background:

  • Tuberculosis (TB) remains a global health challenge requiring novel therapeutic strategies.
  • Targeting essential Mycobacterium tuberculosis (Mtb) enzymes absent in humans offers a path to selective drug development.
  • Mycobacterium tuberculosis salicylate synthase (MbtI) is a validated target crucial for Mtb virulence.

Purpose of the Study:

  • To design, synthesize, and evaluate novel 5-phenylfuran-2-carboxylic acid derivatives as MbtI inhibitors.
  • To optimize lead compounds for enhanced antitubercular activity and favorable safety profiles.
  • To investigate the potential of polymersomes for targeted delivery of antitubercular agents.

Main Methods:

  • Structure-based drug design and synthesis of 5-phenylfuran-2-carboxylic acid derivatives.
  • Enzyme inhibition assays to determine IC50 values against MbtI.
  • In vitro antitubercular activity testing against M. bovis BCG.
  • Encapsulation of optimized compounds into poly(2-methacryloyloxyethyl phosphorylcholine)-poly(2-(diisopropylamino)ethyl methacrylate) (PMPC-PDPA) polymersomes (POs).

Main Results:

  • Several potent MbtI inhibitors with significant antitubercular activity were identified.
  • Optimized compound 5-(3-cyano-5-isobutoxyphenyl)furan-2-carboxylic acid (1e) showed strong MbtI inhibition (IC50 = 11.2 μM) and in vitro activity (MIC99 = 32 μM).
  • Esters of 1e were successfully loaded into PMPC-PDPA polymersomes and demonstrated reduced Mtb viability upon intracellular delivery.

Conclusions:

  • Novel 5-phenylfuran-2-carboxylic acid derivatives are effective MbtI inhibitors with promising antitubercular properties.
  • Polymersomes serve as an effective drug delivery system for targeting intracellular mycobacteria.
  • This study lays the groundwork for developing MbtI-targeted therapies using polymersome-based drug delivery for tuberculosis.